journal
https://read.qxmd.com/read/38452263/current-state-of-dermatology-mobile-applications-with-artificial-intelligence-features-a-scoping-review
#21
JOURNAL ARTICLE
Shannon Wongvibulsin, Matthew J Yan, Vartan Pahalyants, William Murphy, Roxana Daneshjou, Veronica Rotemberg
IMPORTANCE: With advancements in mobile technology and artificial intelligence (AI) methods, there has been a substantial surge in the availability of direct-to-consumer mobile applications (apps) claiming to aid in the assessment and management of diverse skin conditions. Despite widespread patient downloads, these apps exhibit limited evidence supporting their efficacy. OBJECTIVE: To identify and characterize current English-language AI dermatology mobile apps available for download, focusing on aspects such as purpose, supporting evidence, regulatory status, clinician input, data privacy measures, and use of image data...
March 7, 2024: JAMA Dermatology
https://read.qxmd.com/read/38446470/immunohistochemistry-for-diagnosing-melanoma-in-older-adults
#22
JOURNAL ARTICLE
Kenechukwu Ojukwu, Megan M Eguchi, Adewole S Adamson, Kathleen F Kerr, Michael W Piepkorn, Stacey Murdoch, Raymond L Barnhill, David E Elder, Stevan R Knezevich, Joann G Elmore
IMPORTANCE: Pathologic assessment to diagnose skin biopsies, especially for cutaneous melanoma, can be challenging, and immunohistochemistry (IHC) staining has the potential to aid decision-making. Currently, the temporal trends regarding the use of IHC for the examination of skin biopsies on a national level have not been described. OBJECTIVE: To illustrate trends in the use of IHC for the examination of skin biopsies in melanoma diagnoses. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cross-sectional study was conducted to examine incident cases of melanoma diagnosed between January 2000 and December 2017...
March 6, 2024: JAMA Dermatology
https://read.qxmd.com/read/38446459/evolving-trends-in-immunohistochemistry-use-in-dermatopathology
#23
JOURNAL ARTICLE
Alexandra Flamm
No abstract text is available yet for this article.
March 6, 2024: JAMA Dermatology
https://read.qxmd.com/read/38446447/anatomic-subtype-differences-in-extramammary-paget-disease-a-meta-analysis
#24
JOURNAL ARTICLE
Nour Kibbi, Joshua L Owen, Brandon Worley, Jake X Wang, Vishnu Harikumar, Sumaira Z Aasi, Sunandana Chandra, Jennifer N Choi, Yasuhiro Fujisawa, Christos Iavazzo, John Y S Kim, Naomi Lawrence, Mario M Leitao, Allan B MacLean, Jeffrey S Ross, Anthony M Rossi, Sabah Servaes, Michael J Solomon, Murad Alam
IMPORTANCE: Extramammary Paget disease (EMPD) is a rare, highly recurrent cutaneous malignant neoplasm of unclear origin. EMPD arises most commonly on the vulvar and penoscrotal skin. It is not presently known how anatomic subtype of EMPD affects disease presentation and management. OBJECTIVE: To compare demographic and tumor characteristics and treatment approaches for different EMPD subtypes. Recommendations for diagnosis and treatment are presented. DATA SOURCES: MEDLINE, Embase, Web of Science Core Collection, and Cochrane Reviews CENTRAL from December 1, 1990, to October 24, 2022...
March 6, 2024: JAMA Dermatology
https://read.qxmd.com/read/38446440/erythematous-plaque-studded-with-papules-and-pustules-in-an-immunocompetent-patient
#25
JOURNAL ARTICLE
Ahmad B Shahin, Munir H Idriss, Julia S Lehman
No abstract text is available yet for this article.
March 6, 2024: JAMA Dermatology
https://read.qxmd.com/read/38446433/symptoms-of-cognitive-impairment-among-children-with-atopic-dermatitis
#26
JOURNAL ARTICLE
Emily Z Ma, Hannah R Chang, Sarah Radtke, Joy Wan
IMPORTANCE: Previous studies suggest that atopic dermatitis (AD) is associated with cognitive impairment in children, but these studies have relied primarily on neurodevelopmental diagnoses (rather than symptoms) as proxy measures of cognitive function. It remains unknown if certain subpopulations of children with AD are at greater risk of cognitive impairment. OBJECTIVE: To examine the association of AD with symptoms of cognitive impairment (difficulty in learning or memory) among US children and whether this association varies according to the presence or absence of neurodevelopmental comorbidities (attention-deficit/hyperactivity disorder [ADHD], developmental delay, or learning disability)...
March 6, 2024: JAMA Dermatology
https://read.qxmd.com/read/38416506/patient-reported-outcomes-and-mortality-in-cutaneous-chronic-graft-vs-host-disease
#27
JOURNAL ARTICLE
Emily Baumrin, Daniel B Shin, Nandita Mitra, Joseph Pidala, Najla El Jurdi, Stephanie J Lee, Alison W Loren, Joel M Gelfand
IMPORTANCE: Chronic graft-vs-host disease (GVHD) is associated with impaired quality of life and symptom burden. The independent association of skin involvement with patient-reported outcomes (PROs) and their utility as a clinical prognostic marker remain unknown. Identification of patients with cutaneous chronic GVHD and impaired PROs could assist in initial risk stratification and treatment selection. OBJECTIVE: To compare the association of sclerotic and epidermal-type chronic GVHD with longitudinal PROs and to evaluate whether PROs can identify patients with cutaneous chronic GVHD at high risk for death...
February 28, 2024: JAMA Dermatology
https://read.qxmd.com/read/38416466/incidence-and-factors-associated-with-second-primary-invasive-melanoma-in-norway
#28
JOURNAL ARTICLE
Reza Ghiasvand, Adele C Green, Marit B Veierød, Trude E Robsahm
IMPORTANCE: Patients diagnosed with a primary melanoma are at high risk of subsequent melanomas. Understanding the risk of second primary invasive melanoma and associated factors is crucial to optimize patient follow-up. OBJECTIVE: To assess the incidence rate of second primary invasive melanoma and time between the first and second primary invasive melanoma in the Norwegian population. DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study included data from deidentified records of all invasive melanomas diagnosed in Norway in 2008 to 2020, obtained from the Cancer Registry of Norway...
February 28, 2024: JAMA Dermatology
https://read.qxmd.com/read/38416464/improving-outcomes-in-chronic-graft-vs-host-disease
#29
JOURNAL ARTICLE
Sandra A Mitchell, Edward W Cowen
No abstract text is available yet for this article.
February 28, 2024: JAMA Dermatology
https://read.qxmd.com/read/38416455/spesolimab-response-in-a-girl-with-acrodermatitis-continua-of-hallopeau
#30
JOURNAL ARTICLE
Youcong Wang, Li Zhang, Jie Zheng, Xia Li, Lihong Chen
No abstract text is available yet for this article.
February 28, 2024: JAMA Dermatology
https://read.qxmd.com/read/38381445/cooling-research-fever-in-dermatology-the-role-of-community-service
#31
JOURNAL ARTICLE
Angela L Zhang, Victoria S Humphrey, John C Trinidad
No abstract text is available yet for this article.
February 21, 2024: JAMA Dermatology
https://read.qxmd.com/read/38381443/matching-drug-prices-to-their-clinical-benefit-the-final-frontier
#32
JOURNAL ARTICLE
Edward C F Wilson, Zenas Z N Yiu
No abstract text is available yet for this article.
February 21, 2024: JAMA Dermatology
https://read.qxmd.com/read/38381419/cooling-research-fever-in-dermatology-the-role-of-community-service-reply
#33
JOURNAL ARTICLE
Jocelyn Gandelman, Erin Mathes, Daniel Butler
No abstract text is available yet for this article.
February 21, 2024: JAMA Dermatology
https://read.qxmd.com/read/38381418/use-of-efficiency-frontiers-to-align-prices-and-clinical-benefits-of-biologic-therapies-for-plaque-psoriasis
#34
JOURNAL ARTICLE
Alexander C Egilman, Aaron S Kesselheim, Jerry Avorn, Adam J N Raymakers, Benjamin N Rome
IMPORTANCE: The US lacks a systematic approach for aligning drug prices with clinical benefit, and traditional cost-effectiveness analysis (CEA) faces political obstacles. The efficiency frontier (EF) method offers policymakers an alternative approach. OBJECTIVE: To assess how the EF approach could align prices and clinical benefits of biologic medications for plaque psoriasis and estimate price reductions in the US vs 4 peer countries: Australia, Canada, France, and Germany...
February 21, 2024: JAMA Dermatology
https://read.qxmd.com/read/38381410/annular-erythematous-eruption-in-a-pediatric-patient
#35
JOURNAL ARTICLE
Samar Sheriff, Soon Bahrami, Courtney R Schadt
No abstract text is available yet for this article.
February 21, 2024: JAMA Dermatology
https://read.qxmd.com/read/38381409/identifying-core-outcome-domains-in-chronic-skin-disease-using-the-best-worst-scaling-method
#36
JOURNAL ARTICLE
Ali Shields, Frances K Barg, Wendy Smith Begolka, Kathy Sage, Kelly Druby, George C Gondo, David J Margolis, Andrea L Pusic, John S Barbieri
IMPORTANCE: The use of patient-reported outcome measures (PROMs) potentially holds promise as an opportunity to improve outcomes and quality of care for patients with skin disease, but the routine use of PROMs remains limited. While the Patient-Reported Outcomes Measurement Information System (PROMIS) has several strengths and domains relevant to those with chronic skin disease, it is not clear which are most useful. OBJECTIVE: To determine which PROMIS domains are most meaningful to those with chronic skin disease to develop a PROMIS profile that effectively captures the experience of living with these skin diseases...
February 21, 2024: JAMA Dermatology
https://read.qxmd.com/read/38353987/efficacy-and-durability-of-intravenous-ertapenem-therapy-for-recalcitrant-hidradenitis-suppurativa
#37
JOURNAL ARTICLE
Avigdor Nosrati, Peter Y Ch'en, McCall E Torpey, Neda Shokrian, Gretchen Ball, Gabrielle Benesh, Tyler M Andriano, Tian Ran Zhu, Haley D Heibel, H Dean Hosgood, Kristina L Campton, Steven R Cohen
IMPORTANCE: Hidradenitis suppurativa (HS) is a debilitating follicular skin disorder in which bacterial colonization is typical. Oral antibiotic efficacy can be unreliable; however, selective intravenous antibiotics, specifically ertapenem, may provide favorable clinical outcomes. OBJECTIVE: To explore optimal course duration, efficacy, and patient satisfaction associated with intravenous ertapenem for HS. DESIGN, SETTING, AND PARTICIPANTS: This retrospective review of the medical records of 98 patients with HS between 2018 and 2022 measured and evaluated patient outcomes before and after treatment with intravenous ertapenem...
February 14, 2024: JAMA Dermatology
https://read.qxmd.com/read/38353983/lived-experiences-and-fear-of-cancer-recurrence-among-survivors-of-localized-cutaneous-melanoma
#38
JOURNAL ARTICLE
Ayisha N Mahama, Courtney N Haller, Jocelyn Labrada, Christie I Idiong, Alex B Haynes, Elizabeth A Jacobs, Joel Tsevat, Michael P Pignone, Adewole S Adamson
IMPORTANCE: Most of the rapid increase in cutaneous melanoma incidence in the US has been localized disease that is treated surgically and is associated with high survival rates. However, little is known about the psychological well-being of survivors in the US. OBJECTIVE: To explore the lived experiences and fear of cancer recurrence among survivors of localized cutaneous melanoma. DESIGN, SETTING, AND PARTICIPANTS: This was a qualitative and survey-based study that used semistructured interviews and the Fear of Cancer Recurrence Inventory short form (FCRI-SF) survey tool with participants recruited from an academic dermatology practice affiliated with the University of Texas, Austin...
February 14, 2024: JAMA Dermatology
https://read.qxmd.com/read/38353971/deep-vein-thrombosis-and-healing-outcomes-in-patients-with-pyoderma-gangrenosum
#39
JOURNAL ARTICLE
Hannah Zhao, Sidharth K Sengupta, Jonathan M Sisley, Olivia Haddadin, Hailey Pfeifer, Alex G Ortega-Loayza
No abstract text is available yet for this article.
February 14, 2024: JAMA Dermatology
https://read.qxmd.com/read/38353969/balancing-ertapenem-therapy-in-recalcitrant-hidradenitis-suppurativa-with-antibiotic-stewardship
#40
JOURNAL ARTICLE
Haley B Naik
No abstract text is available yet for this article.
February 14, 2024: JAMA Dermatology
journal
journal
44126
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.